Kos Biotechnology Partners Announces Strategic Investment in Golden Age Health to Accelerate Global Access to Rare Disease Therapies
- Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President
NEW YORK and ATHENS, Greece and SINGAPORE, Oct. 26, 2026 /PRNewswire/ — Kos Biotechnology Partners (“Kos”), a global life sciences investment firm bridging the U.S. and European biopharma ecosystems, today announced a strategic investment in Golden Age Health (GAH) through its inaugural fund, Kos BioVentures. As part of this partnership, Alex Tzoukas, Managing Partner and Co-Founder of Kos Biotechnology Partners, will join the Golden Age Health Board of Directors.
Golden Age Health is an innovative…
